These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1389110)

  • 21. Reduction of the number of mice used for potency testing of human and animal rabies vaccines.
    Bruckner L; Palatini M; Ackermann M; Müller HK; Kihm U
    Experientia; 1988 Oct; 44(10):853-7. PubMed ID: 3181371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. G-protein based ELISA as a potency test for rabies vaccines.
    Chabaud-Riou M; Moreno N; Guinchard F; Nicolai MC; Niogret-Siohan E; Sève N; Manin C; Guinet-Morlot F; Riou P
    Biologicals; 2017 Mar; 46():124-129. PubMed ID: 28214171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
    Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
    Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human diploid-cell-culture vaccine for rabies prophylaxis.
    Aoki FY
    Can Med Assoc J; 1979 May; 120(9):1044-6. PubMed ID: 445294
    [No Abstract]   [Full Text] [Related]  

  • 25. A versatile in vitro ELISA test for quantification and quality testing of infectious, inactivated and formulated rabies virus used in veterinary monovalent or combination vaccine.
    Sigoillot-Claude C; Battaglio M; Fiorucci M; Gillet D; Vimort AS; Giraud Y; Laurent S; Vaganay A; Poulet H
    Vaccine; 2015 Jul; 33(32):3843-9. PubMed ID: 26144898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purified chick embryo cell (PCEC) rabies vaccine for human use. Laboratory data.
    Barth R; Gruschkau H; Jaeger O; Milcke L; Weinmann E
    Behring Inst Mitt; 1984 Nov; (76):142-54. PubMed ID: 6525146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
    Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
    J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a quantitative enzyme linked immunosorbent assay for monitoring the Enterovirus 71 vaccine manufacturing process.
    Liu CC; Chang HW; Yang G; Chiang JR; Chow YH; Sai IH; Chang JY; Lin SC; Sia C; Hsiao CH; Chou AH; Chong P
    J Virol Methods; 2011 Sep; 176(1-2):60-8. PubMed ID: 21704080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine.
    Lin G; Huang H; Liu T; He C; Liu J; Chen S; Hou J; Ren Z; Dong W; Wu Y
    J Virol Methods; 2014 Sep; 206():89-94. PubMed ID: 24928690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabies vaccine standardization: International Collaborative Study for the Characterization of the fifth International Standard for Rabies Vaccine.
    Lyng J; Bentzon MW; Ferguson M; Fitzgerald EA
    Biologicals; 1992 Dec; 20(4):301-13. PubMed ID: 1305406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target cells for antibodies detection in rabies vaccine control.
    Fontana D; Prieto C; Kratje R; Etcheverrigaray M
    Vaccine; 2014 May; 32(24):2805-7. PubMed ID: 24631076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new, highly immunogenic duck embryo rabies vaccine.
    Glück R; Wegmann A; Germanier R; Keller H; Hess MW; Kraus-Ruppert R; Wandeler AI
    Lancet; 1984 Apr; 1(8381):844-5. PubMed ID: 6143152
    [No Abstract]   [Full Text] [Related]  

  • 34. THE VALUE OF DUCK-EMBRYO VACCINE AND HIGH-EGG-PASSAGE FLURY VACCINE IN EXPERIMENTAL RABIES INFECTION IN GUINEA-PIGS.
    VEERARAGHAVAN N; SUBRAHMANYAN TP
    Bull World Health Organ; 1963; 29(3):323-30. PubMed ID: 14065070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
    Zhang S; Liu Y; Zhang F; Hu R
    Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis.
    Sudarshan MK; Mahendra BJ; Madhusudana SN; Narayana DH; Sanjay TV; Gangaboraiah ; Anandagiri MS
    Hum Vaccin; 2005; 1(5):187-90. PubMed ID: 17033270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd.
    Kulkarni PS; Sahai A; Gunale B; Dhere RM
    Expert Rev Vaccines; 2017 Apr; 16(4):303-311. PubMed ID: 28276304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ALLERGIC REACTION TO A VACCINE PREPARED FROM DUCK EMBRYO IN PERSONS TREATED WITH A FERMI TYPE OF VACCINE].
    PACHECO GA
    Rev Paul Med; 1964 Feb; 64():107-10. PubMed ID: 14137178
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate].
    Zanetti F; Rudak L; Micucci M; Grand DC; Luque A; Russo S; Taboga O; Pérez O; Calamante G
    Rev Argent Microbiol; 2012; 44(2):75-84. PubMed ID: 22997764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.